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Abstract.  Human lysosomal oe-galactosidase  A  (o~-Gal 
A) was stably overexpressed in CHO cells and its bio- 
synthesis and targeting were investigated. Clone 
AGA5.3-1000Mx, which was the highest enzyme over- 
expressor, produced intracellular ot-Gal A levels of 
20,900 U/mg ('~100 gg of enzyme/107 cells) and 
secreted ~13,000  U (or 75/~g/107 cells) per day. U1- 
trastructural examination of these ceils revealed 
numerous 0.25-1.5  #m crystalline structures in dilated 
trans-Golgi network (TGN) and in lysosomes which 
stained with immunogold particles using affinity- 
purified anti-human ot-Gal A antibodies. Pulse-chase 
studies revealed that ~65 % of the total enzyme syn- 
thesized was secreted, while endogenous CHO 
lysosomal enzymes were not, indicating that the a-Gal 
A  secretion was specific. The recombinant intracellu- 
lar and secreted enzyme forms were normally 
processed and phosphorylated; the secreted enzyme 
had mannose-6-phosphate moieties and bound the im- 
mobilized 215-kD mannose-6-phosphate receptor 
(M6PR).  Thus, the overexpressed enzyme's selective 
secretion did not result from oversaturation of the 
M6PR-mediatexl  pathway or abnormal binding to the 
M6PR.  Of note, the secreted ot-Gal A  was sulfated 
and the percent of enzyme sulfation decreased with 
increasing amplification, presumably due to the inac- 
cessibility of the enzyme's tyrosine residues for the 
sulfotransferase in the TGN.  Overexpression of human 
lysosomal a-N-acetylgalactosaminidase and acid sphin- 
gomyelinase in CHO cell lines also resulted in their 
respective selective secretion. In vitro studies revealed 
that purified secreted a-Gal A was precipitated as a 
function of enzyme concentration and pH, with 30 % 
of the soluble enzyme being precipitated when 10 
mg/ml of enzyme was incubated at pH 5.0. Thus, it is 
hypothesized that these overexpressed lysosomal en- 
zymes are normally modified until they reach the TGN 
where the more acidic environment of this compart- 
ment causes the formation of soluble and particulate 
enzyme aggregates. A  significant proportion of these 
enzyme aggregates are unable to bind the M6PR and 
are selectively secreted via the constitutive secretory 
pathway,  while endogenous lysosomal enzymes bind 
the M6PRs and are transported to lysosomes. 
M 
AMMALIAN  expression systems have proven invalu- 
able for the stable, high-level production of human 
proteins which require various co- and posttrans- 
lational modifications for folding, stability, function and/or 
subcellular targeting (Wasley et al., 1987; Walls et al., 1989; 
Papkoff, 1989; Israel and Kaufman, 1989). Among available 
systems, SV-40-based  vectors containing  dominant select- 
able markers, such as dihydrofolate reductase, for gene am- 
plification permit the stable  integration  and high-level ex- 
pression of the selectable marker and gene of interest in 
mammalian cells  (Kaufman,  1990a,b).  Overexpression  of 
human cDNAs in CHO cells results in the synthesis of re- 
combinant  proteins  with  posttranslational  modifications 
similar to those of their native counterparts (Kaufman et al., 
1988). These systems produce such large amounts of the re- 
combinant protein that they facilitate efficient characteriza- 
tion of  the protein's biosynthesis and targeting, as well as pro- 
vide abundant protein for therapeutic evaluation. Examples 
of biologically functional human glycoproteins produced in 
CHO  cells  with  amplifiable  vectors include B-interferon 
(McCormick et al., 1984), granulocyte-macrophage-stimu- 
lating factor (Wong et al., 1985), tissue plasminogen activa- 
tor (Kaufman et al.,  1985), factor vm  (Kaufman et al., 
1988),  CD4  (Davis et al.,  1990), and the glucocorticoid 
receptor (Alksnis et al.,  1991). 
Most of the human cDNAs overexpressed in CHO cells 
have encoded either secreted or membrane-associated pro- 
teins  that  were appropriately  targeted.  However, proteins 
trafficked  to specific organelles  have not been stably ex- 
pressed, with the exception of the two resident endoplasmic 
reticulum (ER) ~  proteins,  ERp72 and protein disulfide iso- 
merase (Dorner et al., 1990). After stable, high-level over- 
production,  each of these glycoproteins, which normally are 
1. Abbreviations used in this paper: c~-Gal A, ot-galactosidase; dFCS, dia- 
lyzed  FCS; ER,  endoplasmic  reticulum;  MEP,  major ~creted protein; 
M6PR, marmose-6-phosphate receptor; Mx, methotrexate; PCR, polymer- 
ase chain reaction; TGN, trans-Golgi  network. 
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geted to the ER and selectively  secreted. However, no mech- 
anism  for their  selective  secretion  was  identified.  Thus, 
studies  of the biosynthesis  and targeting of overproduced 
lysosomal,  ER,  Golgi,  or secretory  pathway elements  in 
CHO cells would determine if other proteins with specific 
intracellular  trafficking  signals  are mislocalized  and/or se- 
lectively  secreted. 
Among  lysosomal  enzymes,  human c~-galaetosidase A 
(c~-Gal A, ~-~-galactosidase  galactohydrolase, EC 3.2.1.22) 
provides a prototype for studies of the biosynthesis and tar- 
geting of overexpressed lysosomal hydrolases. Human c~-Gal 
A is encoded by a single 14-kb housekeeping gene (Bishop 
et al.,  1988b)  localized  to chromosomal  region Xq21.33- 
Xq22 (Desnick et al., 1987). The processed  1.4-kb c~-Gal A 
transcript, which encodes 429 amino acids including a signal 
peptide of 31 residues (Bishop et al.,  1988a),  is translated 
and co-translationally glycosylated in the ER into an m50- 
kD precursor glycopeptide. After cleavage of the signal pep- 
tide, the glycopeptide undergoes modification of its N-linked 
oligosaccharide moieties in the Golgi apparatus, and then is 
transported to the lysosome via the mannose-6-phosphate 
receptor  (M6PR)-mediated  pathway (Lemansky  et  al., 
1987). The mature lysosomal form of the enzyme is a soluble 
homodimeric  glycoprotein with a native molecular mass of 
101 kD (Bishop and Desnick, 1981). Mutations in the ~-Gal 
A gene that result in deficient or absent enzymatic activity 
cause Fabry disease, a disorder characterized by progressive 
glyeosphingolipid  deposition in vascular lysosomes leading 
to early demise from renal, cardiac, or cerebral vascular dis- 
ease (Desnick and Bishop,  1989). 
In this communication,  the stable, amplified overexpres- 
sion of human lysosomal enzymes in mammalian cells is de- 
scribed. Amplified expression of human ~-Gal A resulted in 
such high intracellular levels of the recombinant enzyme that 
crystalline  structures were observed  in membrane-limited 
structures  presumed  to  be  dilated  trans-Golgi network 
(TGN) and in lysosomes. Of note, the majority of the overex- 
pressed  enzyme  was  selectively  secreted  into the culture 
medium.  Among possible mechanisms for the selective  se- 
cretion, several were eliminated: an altered eDNA construct, 
lack of the M6PR signal, and low affinity for the M6PR, sug- 
gesting  that an alternative mechanism  was responsible  for 
the selective  secretion  of this lysosomal  hydrolase. 
Material and Methods 
Construction of Plasmid p91-AGA for 
a-Gal A Overproduction 
Construction  of p91-AGA and demonstration of its transient  expression have 
been previously described (Bishop et al., 1988). Briefly, the full-length hu- 
man a-Gal A eDNA was digested with BamHI and PstI and the 1.45-kb in- 
sen fragment was  purified and force-subcloned into plasmid pGEM-4 
(Promega Biotec, Madison, WI) resulting in pGEM-AGA126. This plasmid 
was digested with HindHI, end-filled using Klenow polymerase and ligated 
to EcoRI linkers.  After digestion with EcoRI, the L45-kb fragment was 
purified and cloned into the EcoRI site of the mammalian expression vector 
pg1023(B)  resulting in the construct, p91-AGA. The analogous expression 
constructs for human r  (designated  tO1-AGB) 
and acid sphingomyelinase  (designated  IO1-ASM) and the respective tran- 
sient expression of each in COS-1 cells have been previously  described 
(Wang et al.,  t990; Schuchman et al.,  1991). 
Polymerase Chain Reaction Amplification, oeGal A 
mRNA, and Gene Copy Number 
Polymerase chain reaction (PCR) amplification of the integrated human 
~x-Gal A  eDNA sequences was performed using a  DNA thermal cycler 
(Perkin-Elmer Cetus Instruments, Norwalk,  CT).  Primers designed to 
specifically amplify the ~x-Gal  A coding sequence were used as previously 
described  (Sakuraba et al.,  1990).  The PCR reactions  were performed in- 
dependently three times, and the products were ligated into pGEM-4Z for 
double-stranded sequencing (Sanger et al.,  1977). 
Total RNA from CHO ceils was isolated and mRNA levels were esti- 
mated by dot-blot hybridization with 32P-labeled c~-Gal A eDNA to 10 #g 
of  total RNA on nitrocellulose filters (Sambrook et al., 1990) using increas- 
ing amounts of the ot-Gal A riboprobe for quantitation (Sakuraba et al., 
1992). The filters were prehybridized overnight  and then hybridized for 16 h 
with the 32P-labeled ~-Gal A eDNA probe. After washing,  the filter was 
exposed to Kodak X-Omat AR film (Eastman Kodak Co., Rochester, NY) 
for 6 h using two Cronex Lightening Plus (DuPont Instruments, Wilming- 
ton, DE) intensifying  screens. 
The ~-Gal A gene copy number was estimated by Southern hybridization 
analysis (Sambrook et al., 1990). Briefly, genomic DNA was isolated from 
,-Gal  A  transfected  clones AGAS.3-0Mx  and AGAS.3-1000Mx  and di- 
gested with EcoRI overnight.  Aliquots (10 #g DNA) were electrophoresed 
in 0.7% agarose next to known amounts of human r  A eDNA (1, 0.5, 
0.25,  and 0.125 ng).  After Southern transfer,  the filter was hybridized as 
above and the ~-Gal A DNA bands were excised and quantitated by scintil- 
lography. 
Cell Culture, Electrotransfection, and 
Gene Amplification 
DG44 dhfr- CHO cells were grown in DME with 0.05 mM hypoxanthine, 
0.008 mM thymidine, 10% FCS, and antibiotics at 37~  in 5% CO2 using 
standard techniques.  After  transfection,  the  recombinant dyr-  DG44 
CHO lines were grown in DME supplemented with 10% dialyzed FCS 
(dFCS) in the absence or presence of methotrexate (Mx). 
For electroporation, cells were trypsinized and centrifuged at 1000 g for 
10 rain at room temperature. The pellet was washed once with DME sup- 
plemented with 10% FCS and twice with ice-cold electroperation buffer 
(phosphate buffered sucrose; 272 mM sucrose,  7 mM sodium phosphate, 
pH 7.4, containing 1 mM MgCI2). Cells were then resuspended in phos- 
phate buffered  sucrose at ~0.65-1.0  ￿  107 cells/m].  The cell suspension 
(0.8 nil) was placed in a 0.4-cm gap cuvette (Bio-Rad Laboratories, Rich- 
mond, CA) and 5-20 #g of plasmid DNA was added. After 10 rain on ice, 
the cuvette was placed in the chamber of the "Gene Pulser" electroporation 
unit (Bio-Rad  Laboratories) and was pulsed once at 400 V, 25 #E The 
cuvette containing the pulsed cells was placed on ice for 10 rain and then 
the cells were removed and placed in 100 mm tissue culture dishes contain- 
ing 10 m] of DME supplemented with 10% FCS. For stable expression,  the 
transfected DO44 cells were grown for 48 h, removed from the culture dish 
by trypsinization, and replated at a 1:15 ratio in DME supplemented with 
10%  dFCS.  The media was replaced every 4  d.  After 2  wk of growth, 
'~1,000 cell foci became visible, and 100 individual clones were isolated 
with cloning rings. The 15 clones that expressed the highest levels of a-Gal 
A activity were subjected to amplification en masse by step-wise growth in 
0.02 and then 0.08 /zM Mx.  Of these, three clones, AGAS, AGA9, and 
AGAll, which had the highest enzymatic activities,  were further amplified 
by sequential  growth in 1.3, 20, 40, 80, 250,  500, and 1000/~M Mx. 
Butyrate stimulation  of the c~-Gal  A expressing CHO cells was performed 
as previously described (Dorner et al.,  1989). Briefly, cells were plated in 
100-ram dishes and allowed to grow in 10 m] of DME supplemented with 
10% dFCS for 2 d. The media was removed and replaced  with 10 m] of 
DME supplemented with 10% dFCS containing 5 mM sodium butyrate. 
Cells were incubated for 16 h at 37~  in a CO2 incubator, and then cells 
and culture media were harvested and the ~-Gal A activity was determined. 
Ultrastructural and Immunolabeling Studies 
AGAS.3-1000Mx cells  were grown to  confluency  in 100-ram dishes.  After 
trypsinization (0.25% trypsin, EDTA), they were washed twice in PBS and 
pelleted at 1,500 g for 5 rain at room temperature. Cells were then fixed 
for I h with 3 % glutaraldehyde  in PBS, followed by fixation in PBS-butYered 
1% OsO4 for 30 min at room temperature. Samples were then dehydrated 
with graded steps of ethanol, infiltrated with propylene oxide, and embed- 
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1-#m sections were cut from representative areas. Ultrathin sections were 
prepared and stained with uranyl acetate and lead citrate, and then were 
viewed with an electron microscope (JEM 100CX, Jeol USA, Peabody, MA). 
For immunodetection, sections were prepared as above, and after embed- 
ding,  they  were  mounted  on  Formvar-coated  nickel  grids  (Formvar 
Scientific, Marietta, OH), incubated with goat serum in PBS for 30 min at 
37~  to block nonspecific binding, washed six times with PBS, and then 
incubated with affinity-purified rabbit anti-c~-Gal A antibodies for 1 h. The 
sections were washed extensively as above and then incubated with 10-ran 
gold particles conjugated to protein A (Amersham Corp., Arlington, IL) 
for  1 h  at 37~  After washing with PBS, sections were fixed with 3% 
glutaraldehyde in PBS for 15 min at room temperature, washed again with 
PBS, and then examined under the electron microscope. 
Metabolic Labeling Experiments 
Confluent cultures  of the  indicated  subclones in  100-ram  dishes were 
washed once with 5 ml of methionine-free DME and then incubated for 30 
min in 5 ml of methionine-free DME in a 370C incubator. The media was 
replaced with  1 mi of methionine-free DME containing 10%  dFCS and 
50-100 t~Ci of [35S]methionine.  After incubation at 37"C for 3-5 min, the 
radioactive media was removed and the cells were washed twice with DME 
containing 10% FCS. The cells were chased for the indicated times in 5 ml 
of DME containing 10% FCS and 2 mM methionine. For overnight label- 
ing, cultures received 5  ml of methionine-free DME supplemented with 
dFCS, glutamine, antibiotics, and 200 #Ci of [3~S]methionine. 
For 32p-labeling,  the cells were washed with phosphate-free DME sup- 
plemented with 10%  dFCS and incubated with 1 mCi of [32p]orthophos- 
phate for 24 h at 370C  with 5% CO2.  For [35S]sulfate labeling, confluent 
cultures in  100-ram  dishes were switched to  sulfate-free DME  supple- 
mented with 10% dFCS. After addition of [35S]sulfate (50-100 #Ci), the 
cultures were incubated in a 370C-CO2  incubator for 24 h. The cells and 
media were harvested for analysis as described above. 
Antibody Production and 
lmmunoprecipitation Studies 
Monospecific ~-Gal A antibodies were raised in New Zealand white rabbits 
initially  immunized with  250  /~g  of purified  recombinant cr  A  in 
Freund's complete adjuvant. The rabbits were boosted with 100/~g of ~-Gal 
A in Freund's incomplete adjuvant 6 wk later and serum was collected 8 
and 12 d later. Subsequent boosts (100 tzg) were given every 2 mo followed 
by bleeding 10 d later. 
To affinity purify the rabbit anti-human-a-Gal A  antibodies, purified 
recombinant ~-Gal A was coupled to 10 mi of Affigel-15 at a concentration 
of 1 mg protein per milliliter gel, according to the manufacturer's instruc- 
tions (Bio-Rad Laboratories). Immune serum (10 rni) was chromatographed 
over the 10-mi Affigel-cc-Gal A column, washed with 200 ml of 10 mM Tris 
buffer, pH 7.5, followed by 200 ml of 10 mM Tris buffer, pH 7.5, containing 
500 mM NaCI. The antibodies were eluted with 30 ml of 100 mM glycine, 
pH 2.5, into a tube containing 5 rnl of 1 M Tris buffer, pH 8.0. The antibod- 
ies were concentrated and resuspended in 10 mM Tris buffer, pH 7.5, with 
a Centricon-30 concentrator (Amicon Corp., Beverly,  MA). 
For immunoprecipitation studies, cells were lysed by the following pro- 
cedure. Cells grown in 100-mm culture dishes were washed twice with 5 
ml of PBS and 1 ml of lysis buffer (50 mM sodium phosphate, pH 6.9,  150 
mM NaC1, I mM EDTA, 1% NP-40, and 0.2 mM PMSF) was added to each 
dish. After incubation at 4~  for 10 min, the lysates were transferred to 
1.5-ml  microcentrifuge tubes. Cell debris was removed by centrifugation 
(8,000  g  for 15 min at 40C). 
Immunoprecipitation was carried out as previously described (Sambrook 
et al.,  1990).  Briefly, 0.5 mi of cell lysate or culture media was placed in 
a  1.5-ml  microcentrifuge tube and 50/~1 of preimmune rabbit serum was 
added. The mixture was incubated at 4~  for 1 h with gentle agitation. 50 
/,1 of Pansorbin (Calbiochem Corp., La Jolla, CA) was added and incuba- 
tion was continued for 30 rain. The mixture was clarified by centrifugation 
at  8,000  g  for  5  min,  10  #1  of  monospecific affinity-purified rabbit 
anti-buman-~x-Gal A  antibody was added, and the mixture was then in- 
cubated for an additional 1 h at 4~  with gentle rocking. Pansorbin (100 
/~1) was added and the incubation was continued for 30 min as above.  The 
tertiary  Staphylococcus  aureus  cell-antibody-antigen complex  was  col- 
lected by centrifugation as above.  The supernatant was discarded and the 
pellet was washed successively with (a) NEP buffer (50 mM sodium phos- 
phate, pH 6.5, 150 mM NaCI, 1 mM EDTA, 1% NP-40, 0.25 % gelatin) sup- 
plemented with 0.5 M  NaCI) (b) NEP buffer with 0.1% SDS, and (c)  10 
mM Tris buffer,  pH 7.5, containing 0.1% NP-40.  The immunoprecipitated 
protein was denatured by heating at 100~  for 5 min in the presence of 2% 
SDS and 100 mM dithiothreitol. S. aureus cells were removed by centrifu- 
gation at 8,000 g  for 5 min at room temperature. 
For quantitative immunoprecipitation, the total a-Gal A activity in the 
cell lysate and 10 ml of media was determined. To aliquots of the cell lysate 
and media, each containing 100 U of cx-Gal A, a fourfold excess of rabbit 
anti-human cr  A antibodies was added, and then the volume of each 
was adjusted to 0.5 ml with lysis buffer.  Immunoprecipitation was carried 
out as above. This procedure reproducibly immunoprecipitated >  99 % of 
human r  A  in the cell lysate or medium. The polyclonal antibody 
weakly cross-reacted with the CHO c~-Gal A. Similarly,  the rabbit anti-hu- 
man ~-hexosaminidase ~  chain antibodies quantitatively immunoprecipi- 
tated human or CHO/~-hexosaminidase A and B isozymes. The standard 
incubation mixture described above contained 1/~1 of the antibody and the 
quantitative immunoprecipitation incubations were performed as described 
above for a-Gal A. 
To quantitate the percent secretion of human c~-Gal A and endogenous 
CHO ~-hexosaminidases A and B, "~107 cells were labeled with 50 #Ci of 
[3SS]methionine for 2 h as above, and then chased with 5 ml of DME con- 
taining 10% FCS and 2 mM methionine for 16 h. After immunoprecipita- 
tion of the intracellular and secreted a-Gal A or CHO B-hexosaminidases, 
the radioactivity of the immunoprecipitated enzyme was determined in 10 
ml of liquid scintillation fluid (Aquasol; New England Nuclear, Boston, 
MA) using an LKB 1219 Rack.Beta scintillation counter. The total radiola- 
beled c~-Gal A or total CHO ~-hexosaminidases in the ceils and media was 
calculated based on the cpm of the immunoprecipitated 100 U of either en- 
zyme from each source. 
SDS-PAGE and Autoradiography 
PAGE was carried out under reducing conditions as described by Laemmli 
(1970) in 1.5-ram thick slab gels containing 10% acrylamide. The gel was 
fixed in 10% acetic acid and 20% methanol for 30 rain and then soaked in 
Amplify (Amersham Corp.) for 30 min with agitation. Gels were vacuum 
dried for 90 min (Hoeffer Scientific Instruments, San Francisco, CA) and 
then autoradiographed with Kodak X Groat AR film (Eastman Kodak Co.) 
for 4-24 h. 
MtPR Affinity Chromatography 
The 215-kD M6PR coupled to Affigel-10 (Bio-Rad Laboratories) at a con- 
centration of  0.4 mg/ml of  packed gel was a generous gift of Dr. Smart Korn- 
reid  (Washington  University,  St.  Louis,  MO).  Media  containing  the 
secreted enzyme(s) was mixed 1:1 with binding buffer (50 mM imidazole, 
pH 7.0, 150  mM NaC1,  0.05%  Triton X-100,  5  mM sodium-B-glycerol- 
phosphate, 0.02%  sodium azide) and applied to the 1.5  x  0.8-cm M6PR 
column at a flow rate of 0.3 ml/min. After sample application (5 ml), the 
column was washed with 10 mi of binding buffer and then eluted with an 
exponentially increasing gradient of M6P as described by Dung and Sa- 
hagian (1990).  Fractions (1.0 mi) were collected and assayed for enzymatic 
activity using the appropriate 4-methylumbelliferyl-substrate as described 
below. 
To assess the amount of purified, secreted recombinant a-Gal A  that 
bound  the  M6PR  as  a  function  of enzyme  concentration,  increasing 
amounts of enzyme (200-10,000,000 U) were applied in a constant volume 
of 100 t~l of  binding buffer to the 1-ml M6PR column at pH 6.0. The receptor 
column was washed with five column volumes of binding buffer and then 
eluted with five column volumes of binding buffer containing 5 mM M6P. 
The enzymatic activity bound and eluted under these conditions was deter- 
mined as above. In addition, 300,000  U of  highly concentrated recombinant 
c~-Gal A  (30  mg/ml) was intra- and intermoleculafly cross-linked with 
1-ethyl-3-(3-dimethylaminopropyl-cardodimide),  and used for the receptor 
binding assay as described above. 
To evaluate the affinity of the bound enzyme for the M6PR column, in- 
creasing concentrations of purified,  secreted ~x-Gal A  were applied as 
above. After washing the column with binding buffer to elute unbound en- 
zyme, the bound <x-Gal A was eluted in two fractions: one with five column 
volumes of binding buffer containing 0.005  mM M6P to release enzyme 
bound with low affinity, followed by a second with five column volumes of 
binding buffer containing 5 mM M6P to elute the enzyme bound with high 
affinity. The relative affinity of the bound enzyme for the receptor was ex- 
pressed as one over the percent of total enzyme eluted at 0.005  mM M6P. 
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The possible formation of insoluble e~-Gal A aggregates at varying enzyme 
and hydrogen ion concentrations was investigated. Using a stock solution 
of purified, secreted c~-Gal A (16 rng/mi in 10 mM Tris buffer, pH 7.0), ap- 
propriate aliquots were placed in glass borosilicate tubes and the volumes 
were brought to 200 t~l with distilled water so that with the addition of 100 
#1 of the appropriate buffer (0.5 M  2-(N-morpholino)ethanesulfonic acid, 
at pH 5.0, 5.5, 6.0, 6.5, or 7.0), the final ot-Gal A concentrations  (0.1-10 
mg/ml) would be achieved  at specific  pH values. After incubation  for 10 
win at room  temperature,  the turbidity  of each solution  was determined  by 
measuring the oD at 650 rim in a spectrophotometer  (Spnctronic  1201, Mil- 
ton Roy Co., Rochester, NY) using a 1-cm path cuvette. As a control, 1 
m~/ml of purified,  secreted  c~-Gai A was mixed with increasing BSA con- 
centrations (0.1-10 mg/ml), and the turbidity  of each solution was deter- 
mined. Similar  experiments  were  performed  with solutions  of r  al A (10 
mg/ml) and BSA (2 mg/ml) at decreasing pH (from pH 7.0 to 5.0).  After 
incubation and centrifugetion as above, the supernatants and pellets were 
subjected to SDS-PAGE. 
Enzyme and Protein Assays 
The r  A activities in the cell lysates and media were determined using 
5  mM 4-methylumbelliferyl-c~-n-galactopyranoside (4MU-c~-Gal)  (Gen- 
zyme Corp., Cambridge, MA) as previously described (Bishop and Des- 
nick, 1981).  Briefly, a stock solution of 5 mM 4MU-~-Gal was prepared 
in 0`1 M citrate/0.2 M phosphate buffer, pH 4.6, in an ultrasonic bath. The 
reaction  mixture,  containing  10-50  ttl of  cell extract  and 150 ~1 of  the stock 
substrate solution, was incubated at 37~  for 10-30 rain. The reaction was 
terminated with the addition of 2.3 ml of0`l M ethylanediamine. The fluo- 
rescence was determined using a Ratio-2 System Fluorometer (Optical Tech- 
nology Devices, Etmsford, NY).  1 U of activity is the amount of enzyme 
that hydrolyzed 1 nmole of substrate per hour. The activities of wmannosi- 
dase,  ~-galactosidase,  /3-hexosaminidase,/5-glucuronidase, acid phospha- 
tase, and c~-N-acetylgalactosaminidase were measured using the appropriate 
4-methylumbelliferyl substrate. The activity of acid sphingomyelinase was 
determined according to Gal et al.  (1975).  Protein concentrations were 
quantitated by the fluorescamine method (Bohlen et al.,  1973) as modified 
by Bishop et al,  (1978). 
Results 
Transfection and Amplification of  p91-AGA in dhfr- 
ClIO Cells 
Recombinant clones stably expressing human ~-Gal A were 
obtained by electrotransfection of dhfr- DG44 CHO cells 
with the expression vector p9102303) (Wong et al.,  1985) 
containing the mm'ine dihydrofolate reductase eDNA as the 
selectable marker and the full-length human c~-Gal A eDNA 
(designated p91-AGA).  Initial growth of transfected cells in 
medium lacking nucleosides resulted in over 1,000 positive 
clones, from which 100 were isolated and found to express 
o~-Gal A  at levels ranging  from 200-1,800  U/rag  protein 
(data not shown). The three subelones with the highest cx-Gal 
A  activities (designated AGAS,  AGA9,  and AGAll)  were 
grown in the presence of 0.02 and then 0.08 #M Mx to se- 
quentially amplify the integrated p91-AGA sequences. Two 
AGA5 subclones (AGAS.3 and DGS.9) had the highest intra- 
cellular o~-Gal A  levels (4,900 and 4,200  U/rag protein, 
respectively). Therefore, subclone AGAS.3 was used for sub- 
sequent step-wise amplification with Mx. Table I shows the 
ot-Gal A activities in the sequentially amplified AGAS.3 sub- 
clones which were assayed after growth in the absence of  Mx 
for 3 wk to determine the levels of stably expressed enzyme 
following removal of the selection pressure (Pallavicini et 
al.,  1990).  When grown at the highest Mx concentration 
(1,000/~M), the AGAS.3 subclone (designated AGAS.3-1000 
Mx) expressed 20,900 U/rag of  ot-Gal A activity, an intracel- 
Table L  lntracellular and Secreted Levels of 
Recombinant ot-Gal A from Sequentially Amplified 
AGA5.3 Subclones* 
a-Gal A specific  activity~ 
Cell line  Mx~:  Intraeellular  Secreted 
DG44 
AGA5.3 
175  100 
0.00  360  135 
0.02  417  185 
0.08  687  280 
1.3  3,730  1,630 
20  4,450  1,920 
40  5,220  2,280 
250  9,540  4,250 
500  17,000  8,470 
1,000  20,900  13,100 
* Activities determined 3 wk after Mx removed from the culture media. Values 
are means of triplicate determinations. 
* Mx concentration (#M) used to amplify the expression of p91-AGA. 
w Cellular and secreted specific activities are expressed as units per milligram 
of cell protein. 
lular level "0120-fold greater than that in the untransfected 
parental DG44 ceils. The human c~-Gal A eDNA copy num- 
ber in AGAS.3-0Mx and AGAS.3-1000Mx cells was  esti- 
mated by Southern hybridization analyses to be 4  and 25, 
respectively, whereas the amount of o~-Gal A  transcript in 
AGA5.3-1000Mx cells was at least 10-fold greater than in 
the transfected,  unamplified AGA5.3-0Mx cells  (data  not 
shown). 
Overexpression Results in Crystalline 
Structures Containing Human a-GalA in 
Membrane-Limited Vesicles 
Ultrastructural examination of the stably amplified AGA5.3- 
1000Mx cells revealed numerous 0.25-1.5  #m crystalline 
bodies which had ordered triangular lattices in membrane- 
limited vesicles throughout the cytoplasm (Fig. 1 A and B). 
The repeat within these crystalline structures was ,020 nm. 
These structures were particularly abundant in lysosomes 
(Fig. 1 A) and in vesicles which appeared to be dilated TGN 
(Fig.  1 B) (Hand and Oliver, 1984; Griffiths and Simons, 
1986; McCracken, 1991). Of note, normal Golgi structures 
were not observed in these cells, whereas Golgi complexes 
were readily identified in the parental DG44 cells (Fig. 1 E, 
inset). When osmium-glutaraldehyde-fixed sections of the 
AGA5.3-1000Mx cells were incubated with affinity-purified 
rabbit anti-human o~-Gal A antibodies and then with Protein 
A-conjugated gold,  these crystalline structures were spe- 
cifically stained by the gold particles (Fig. 1 C and D). That 
the crystalline structures were immunogold labeled,  even 
though the sections were fixed in osmium-glutaraldehyde, 
suggested that these structures were primarily, if not solely, 
composed of the human enzyme. 
To determine whether the crystalline structures were pres- 
ent in clones expressing lower levels of ot-Gal  A,  clones 
AGA5.3-0Mx,  -1.3Mx,  -250Mx,  and  -1000Mx  were 
grown to confluency and examined by electron microscopy. 
Although the TGN was increasingly dilated with increasing 
c~-Gal A expression, only the AGA5.3-1000Mx clone con- 
tained  crystalline  arrays  in  lysosomes.  Similarly,  clone 
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CHO cells contain crystalline 
structures of  overexpressed hu- 
man ~-Gal A. Electron micro- 
graphs  of  AGA5.3-1000Mx 
c~lls showing crystalline struc- 
tures in single membrane-lim- 
ited  vacuoles  (A)  and  in 
vesicles, presumably in the di- 
lated tmns-Golgi (B).  (C and 
D)  Immunoelectron  micro- 
scopic localization  of human 
o~-Gal A with 10-nm colloidal 
gold  particles.  (E)  Electron 
micrograph of parental  dfhr- 
DG44  cells;  inset  showing 
Golgi  complex  (arrows)  in 
dJhr-  DG44 cells.  Bars:  (A) 
0.15  ~m;  (B)  0.10  pm;  (C) 
0.31  /~m; (D)  0.19  ftm;  (E) 
1.11/~m,  (inset) 0.5 ftm. 




!  ! 
0  0.08  1~3  4~)  1,000 
Mx  (gM) 
Figure 2. Pulse-chase studies demonstrate increasing secretion of 
overexpressed c~-Gai A in the AGA5.3 amplification series while 
CHO  ~-hexosamirtidase  secretion  remains  unchanged.  AGA5.3 
cells growing at the indicated concentrations  of Mx were labeled 
with 50/~Ci of [35S]methionine for 2 h and then chased with 2 mM 
methionine for 16 h. Human c~-Gai A (e) and CHO/3-hexosamin- 
idases  (-) were individually  immunoprecipitated  from the  cells 
and  media,  and the percent  of each  newly  synthesized enzyme 
that was secreted was determined  as described  in Materials  and 
Methods. 
AGA5.3-1.3Mx was stimulated with 5 mM sodium butyrate 
for  18 h  to increase transcription of the integrated vector 
containing the ~-Gal A cDNA (see below) and then exam- 
ined  ultrastructurally.  Compared  to  the  untreated  clone, 
butyrate treatment resulted  in  the  presence of dilated  or- 
ganeUes including  many membrane-bound structures con- 
taining dense material (not shown). These results indicated 
that crystal formation was  o~-Gal A  concentration  depen- 
dent. Furthermore, to assess whether crystal formation was 
specific to ct-Gal A, clone AGB14.8-1000Mx, which overex- 
presses  t~-N-acetylgalactosaminidase,  was  examined.  No 
crystalline  arrays  were  observed,  but  numerous  dilated 
structures  were  seen  (not  shown)  similar  to  those  in  the 
AGA5.3-1.3Mx  clone,  suggesting  that  expression  of  the 
recombinant ot-N-acetylgalactosaminidase had not reached 
the critical level necessary for crystal formation. 
High Expression Clones Secrete Human c~-Gal  A 
Interestingly,  the  media  from  the  sequentially  amplified 
AGA5.3  subclones  also  had  increasing  concentrations  of 
ct-Gal A  activity (Table I).  Notably, the AGA5.3-1000Mx 
subclone secreted recombinant c~-Gal A at a level of 13,100 
U/rag cell protein per 24-h period (,~18,000 U/ml media), 
or over 130-fold that in the medium of untransfected dhfr- 
DG44 cells. To determine the percentage of newly synthe- 
sized c~-Gal A secreted by the amplified AGA5.3 clones, cells 
selected at sequentially increasing Mx concentrations were 
metabolically labeled with  [35S]methionine,  the intraceUu- 
lar and secreted forms of c~-Gal A were quantitatively immu- 
noprecipitated,  and their radioactivities were determined. 
Table II.  Effect of Butyrate on lntracellular 
and Secreted Levels of Human ot-Gal A from AGA11 
and AGA5 Subclones* 
r  A specific  activity~ 




--  259  102 
+  687 (2.7)11  675 (6.6) 
+, M6Pw  604 (2.3)  700 (6.9) 
-  485  89 
+  1,460 (4.7)  947 (10.6) 
-  12,700  3,830 
+  14,700 (1.2)  9,510 (2.5) 
* Each cell line (rvl0  7 ceils) was grown for 12 h in the presence  or absence 
of 5 mM butyrate,  then the cells  and media  were  harvested  and assayed  for ct-Gal 
A activity. 
~: ct-Gal A specific activity expressed  as units per milligram  of cell protein. 
w  5 mM M6P added to the medium  to block reuptake of secreted enzyme. 
II Fold increases resulting from  butyrate  treatment shown in parentheses. 
Of the total radiolabeled c~-Gal A immunoprecipitated by the 
transfected,  but  unamplified,  AGA5.3-0Mx  clone,  about 
15 % was secreted. With increasing amplification, the per- 
cent of synthesized enzyme secreted increased such that the 
AGA5.3-1000Mx subclone secreted m65%  (Fig.  2). 
Increased ~-Gal A mRNA Results in Increased 
Enzyme Secretion 
To assess whether the secretion of recombinant o~-Gal A by 
the CHO cells was dependent on the amount of the p91-AGA 
transcript, AGA11 (which did not secrete recombinant a-Gal 
A), AGA5.3-0Mx, and AGA5.3-1000Mx cells were grown in 
the presence of 5 mM butyrate, which was previously shown 
to  specifically  increase  transcription  of stably  integrated 
p91023(B) constructs (Andrews and Adamson,  1987;  Dor- 
ner et al., 1989). As shown in Table II, growth of the AGAll 
cells in butyrate resulted in a 2.7-fold increase in the intracel- 
lular o~-Gal A specific activity, while the amount of secreted 
enzyme  increased  over 6.6-fold.  When  5  mM  M6P  was 
added to the growth medium, the intracellular and secreted 
activities reflected the small expected changes due to block- 
ing the  reuptake of the  secreted enzyme.  Of interest,  the 
butyrate stimulation effect was inversely proportional to the 
degree of p91-AGA amplification; for example, the secretion 
of o~-Gal A by the transfected, but unamplified AGA5.3-0Mx 
clone increased 10.6-fold,  whereas the secretion by the most 
highly amplified AGA5.3-1000Mx clone was increased only 
2.5-fold.  Consistent with these results,  butyrate increased 
the p91-AGA mRNA concentrations, as shown for the human 
a-Gal A transcript by RNA/DNA hybridization analyses of 
the  unamplified,  but  transfected,  AGA5.3-0Mx  and  the 
AGA5.3-1000Mx clones (Fig. 3). Thus, the level of o~-Gal A 
secretion was proportional to the c~-Gal A transcript concen- 
tration. 
Secretion of Human t~-Gal  A Is Specific 
To assess whether the secretion of the overexpressed et-Gal 
A  was  due  to  saturation  of the  M6PR-mediated  pathway 
for  lysosomal targeting,  the  culture  medium  from clone 
AGA5.3-1000Mx was assayed for the presence of increased 
levels  of other  lysosomal enzymes  which  would  also  be 
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human  ,~-Gal  A  mRNA  in 
AGA5.3 cells is markedly  in- 
creased  by sodium  butyrate. 
Total  RNAs  (10  ttg)  from 
AGA5.3-0Mx  and  AGA5.3- 
1000Mx  cells  were  applied 
to  a  nitrocellulose  filter  and 
hybridized  to  32p-labeled 
ct-Cral  A eDNA. RNA was  iso- 
lated  before (minus) and after 
(plus)  addition  of 5  mM so- 
dium butyrate to the  growth 
media for 16 h. ot-Gal  A ribo- 
probe indicates the mounts of 
the human cr  A riboprobe 
applied as standards for quan- 
titation  (Sakuraba et al.,  1992). Note that butyrate increased the 
mRNA concentration  even in unamplified AGA5.3 cells. 
secreted by default. As shown in Table III, the activities of 
seven lysosomal enzymes in the medium of AGA5.3-1000Mx 
cells were essentially the  same or lower than those in the 
medium of the dhfr- DG44 parental cell line.  These find- 
ings indicated that the secretion of ot-Gal A was specific and 
was not due to saturation of the M6PR-mediated pathway. In 
addition, the intracellular activities of these enzymes in the 
AGA5.3-1000Mx cells were essentially unchanged or only 
slightly  lower  compared  to  those  in  the  parental  dhfr- 
DG44 cells (Table III), further indicating  that the M6PR- 
mediated pathway was not saturated and that the secretion of 
ct-Gal A  was specific. 
Efforts were then directed to determine if the secretion of 
ot-Gal A was (a) the result of a serendipitous mutation intro- 
duced into the ot-Gal A  eDNA during the construction, in- 
troduction,  or  amplification of the  expression  plasmid in 
the CHO cells (Calos et al., 1983) or (b) due to an alteration 
of the protein-sorting machinery unique to the AGAS.3 sub- 
clones. PCR amplification and sequencing of 10 independent 
subclones  containing  the  ot-Gal A  eDNA insert  from the 
amplified  AGA5.3-1.3Mx  cells  and  the  highly  amplified 
AGA5.3-1000Mx cells revealed that the sequence was com- 
pletely  intact  (data  not  shown).  To  demonstrate  that  the 
selective-secretion phenotype was not specific to the AGA5.3 
clones,  an independent clone,  AGA9,  which was secreting 
Table IV.  Intracellular  and Secreted Levels  of 
Recombinant  c~-Gal A from Sequentially Amplified AGA9 
Subclones* 
c~-Gal A  specific  activityw 
Mx~  Intracellular  Secreted 
0.00  377  200 
0.02  254  120 
0.08  678  424 
1.3  1,565  2,090 
10  2,610  1,970 
20  9,480  7,980 
* Average of three independent determinations. 
~t Mx concentration in/LM. 
w  Cellular and secreted specific activity expressed as units per milligram of cell 
protein. 
little, if any, recombinant o~-Gal A  following removal of the 
selective pressure (i.e., oeGal A activity in the media •200 
U/mg cell protein), was grown in sequentially increasing Mx 
concentrations. After selection in 20/xM Mx, clone AGA9- 
20Mx had intracellular and secreted levels of ~Gal A activ- 
ity of 9,400 U/rag and 7,900 U/mg, respectively (Table IV), 
indicating that the secretion phenotype was not unique to the 
AGA5.3 subclones. 
To further characterize the selective secretion of the over- 
produced ot-Gal A, the biosynthesis and targeting of human 
a-Gal A and human/~-hexosaminidases A and B were deter- 
mined in the series of sequentially amplified AGA5.3 sub- 
clones. The intracellular and secreted forms of [35S]methio- 
nine-labeled r  A and CHO/3-hexosaminidases A and B 
were immunoprecipitated from the cells and media, and the 
percent of each total enzyme that was secreted by the sequen- 
tially amplified AGA5.3 cell lines was determined.  As the 
secretion of recombinant tx-Gal A  increased  dramatically, 
the amounts of endogenous CHO/3-hexosaminidases A and 
B secreted by these cells remained essentially unchanged or 
decreased  slightly  (Fig.  2),  consistent  with  the  selective 
secretion of recombinant o~-Gal A. 
Finally, the possibility that the secretion of human a-Gal 
A was due to the absence of functional M6P moieties on the 
recombinant  enzyme was  assessed.  Parental  dhfr  DG44 
and AGA5.3-1000Mx cells were metabolically labeled with 
Table I11. Intracellular  and Secreted Levels of Various Lysosomai  Enzymes from  Untransfected DG44 and Stably 
Amplified AGAS. 3-1000Mx  Cells* 
Intracellular specific  activity~ 
Enzyme  DG44  AGA5.3-1000Mxw  DG44 
Secreted specific  activity* 
AGA5.3-1000Mx 
a-Galactosidase A  176  +  36  15,500 + 4,400  98  +  61 
ce-N-Acetylgalactosaminidase  11  +  3.2  9.5  +  1.1  50 +  4.5 
/3-Galactosidase  4.0  +  0.2  2.3  +  0.25  12.9 +  5.0 
/3-Glueuronidase  266  +  88  136  +  30  109  +  16 
ct-L-Fueosidase  245  +  34  190  +  27  1,000 +  198 
/3-Hexosaminidase  705  +  161  754  +  340  2,240  +  405 
,-Mannosidase  5.3  +  3.4  7.7  +  3.7  135  +  50 
12,100  +  3,620 
43  + 0.6 
16.9 +  4.4 
73  +  29 
695  +  101 
1,810 +  197 
137  +  24 
* Average of three independent determinations. 
~: Cellular and secreted specific  activity expressed 
w Cells selected at  1,000/~M Mx. 
as units per milligram of cell protein  +  1 SD. 
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creted forms of overexpressed 
human c~-Gal  A are phosphor- 
ylated.  Parental dhfr- DG44 
cells and AGA5.3 cells were 
each  labeled  with  1 mCi  of 
[32p]orthophosphate for 24 h. 
The ceils and media were im- 
munoprecipitated  with affinity- 
purified anti-human c~-Gal A 
polyclonal antibodies and the 
immunoprecipitates were ana- 
lyzed  on  SDS-PAGE. Note 
that the secreted enzyme had 
a  slightly  higher  molecular 
weight than  the  intracellular 
form due to differential post- 
translational modifications. 
[32P]orthophosphate for 12 h and then the cell extracts and 
media  were  immunoprecipitated  and  subjected  to  SDS- 
PAGE.  As  shown  in  Fig.  4,  both  the  intracellular  and 
secreted forms of ot-Gal A were phosphorylated. To demon- 
strate that the phosphate residues were in M6P moieties with 
normal M6PR-binding affinities, the AGA5.3-1000Mx cells 
and  human  fibroblasts  were  grown  in  the  presence  of 
[35S]methionine  and  10  mM  NI-hC1 for  16 h;  then,  their 
secretions were individually chrornatographed on a  l-m1 
column of immobilized 215-kD M6PR (Varki and Komfeld, 
1983) and eluted with an exponential gradient of M6P as de- 
scribed by Dong and Sahagian (1990). As shown in Fig. 5, 
the peaks of secreted ot-Gal A from human fibroblasts (Fig. 
5 A) and AGA5.3-1000Mx cells (Fig. 5 B) were both eluted 
at about 1 mM M6P. Similarly, the radiolabeled peaks for 
the other M6P-containing proteins  secreted in the media 
from each cell line were also eluted at essentially the same 
M6P concentrations. These results indicated that the native 
and  recombinant secreted forms of ct-Gal A  had  normal 
affinities for the M6PR. 
Other Lysosomal Enzymes Overexpressed by CHO 
Cells Are Selectively Secreted 
To determine if the overexpression of other lysosomal en- 
zymes would result in  their selective secretion,  the  full- 
length human cDNAs encoding c~-N-acetylgalactosaminidase 
and acid sphingomyelinase were subeloned into the p91023(B) 
vector. The respective constructs (designated p91-AGB and 
p91-ASM) were individually introduced by electroporation 
into dhfr- DG44 CHO cells, and the expression construct 
in each transfected cell line was amplified as above. The sta- 
ble overexpression of each lysosomal cDNA resulted in high 
levels of intraceUular enzymatic activity as well as the en- 
zyme's selective secretion. For example, following step-wise 
amplification of p91-AGB, the sequentially amplified clones 
expressed increasing intracellular levels of active c~-N-ace- 
tylgalactosaminidase and secreted significant amounts of  this 
lysosomal glycosidase (Table V). Similarly, when the p91- 
ASM construct was amplified, high levels of active recom- 
binant enzyme were detected in the cells and medium (data 
not shown). Both secreted recombinant enzymes had phos- 
phomannosyl signals for receptor-mediated  binding, as dem- 
onstrated by their respective normal  binding  and  elution 
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Figure  5. Recombinant secreted human c~-Gal  A has normal affinity 
for the M6PR. Media (1 ml) from 107 normal human fibroblasts 
and AGA5.3-1000Mx cells grown in the presence of [3SS]methio- 
nine and 10 mM NI-hCI for 16 h, were separately chromatographed 
on a 1-ml column of immobilized 215-kD M6PR and eluted with 
an exponential gradient of M6P (A) according to the method of 
Dong and Sahagian (1990). The elution profiles of the secreted 
ct-Gal A (e) from human fibroblasts (A) and from the ADA5.3- 
1000Mx cells (B) were essentially the same, the peak activities 
eluted at about 1 mM M6P. In addition, the elution profiles for the 
radiolabeled M6P-containing proteins (-) were similar, indicating 
that neither the native or recombinant secreted forms of c~-Gal A 
had decreased affinities for the M6PR. 
profiles  when  chromatographed  on  the  215-kD  M6PR 
column and eluted with M6P (data not shown). 
Sulfation of  Secreted ~-Gal A Decreases 
with Overexpression 
To  determine  if the  intraceUular  and  secreted  forms  of 
recombinant ol-Gal A were posttranslationally sulfated, the 
amplification series of AGAS.3 subclones were each grown 
in medium containing psS]sulfate for 16 h, and the recom- 
binant human c~-Gal A and endogenous CHO/3-hexosamin- 
idases were immunoprecipitated from the cells and the me- 
dia. As shown in Fig. 6, the secreted form of ot-Gai A was 
sulfated, whereas the cellular form was not.  The mdiola- 
beled sulfate moiety on the recombinant secreted enzyme 
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Recombinant cx-GalNAc  from Sequentially Amplified 
AGB14. 8 Subclones* 
a-GalNAc  specific activityw 
Cell line  Mx~  Intracellular  Secreted 
DG44  11  50 
AGB14.8 
0.00  140  66 
0.02  226  ND 
0.08  390  ND 
10  1,130  385 
20  2,270  920 
80  1,910  1,650 
250  2,580  2,100 
1,000  3,730  3,460 
* Average of three independent determinations. 
Mx concentration in #M. 
w  Cellular  and secreted specific activity expressed as units per milligram of cell 
protein. 
was resistant to alkaline hydrolysis, indicating that the link- 
age was a tyrosine-O-sulfate rather than sulfate bound to car- 
bohydrate (Hiittner and Baeuerle,  1988).  Of particular in- 
terest was the finding that the level of radiolabeled sulfate 
incorporated into the secreted ot-Gal  A  decreased as the 
amount of secreted enzyme increased,  while the level of 
radiolabeled  sulfate incorporated into  the  secreted  CHO 
/%hexosaminidases remained essentially unchanged (Fig. 6). 
~-Gal A and ~-N-Acetylgalactosaminidase  Aggregate 
at High Concentration and Low pH 
Since it was conceivable that the overexpression of ~-Gal A 
resulted  in  the  formation of soluble  and  particulate  ag- 
gregates that did not bind to, or were inefficiently  bound by, 
the M6PR and/or the sulfotransferase in the TGN, the possi- 
ble aggregation of ot-Gal A was assessed in vitro at varying 
enzyme and hydrogen ion concentrations. As shown in Fig. 
7 A, the amount of ~-Gal A precipitated from a  10-mg/ml 
solution increased as the pH was lowered; at pH 7.0, less than 
3%  (< 3  ￿  105 U) was precipitated, compared to ,,,30% 
(> 2  ￿  106 U) at pH 5.0. At pH 6.0, the estimated pH of the 
TGN (Griffiths and Simons,  1986),  about 12%  of the en- 
zyme-formed  particulate aggregates that could be pelleted by 
centrifugation at 15,000 g.  Figure 7 B shows that the tur- 
bidity, as a measure of  aggregation (Halper and Stere, 1977), 
of solutions containing 0.1-10 mg/ml of c~-Gal A at either pH 
5.0 or 7.0 increased as a function of enzyme concentration. 
Moreover, the turbidity of a  1-mg/ml ~-Gal A solution was 
essentially unaffected by the presence of increasing albumin 
concentrations from 0.1-10 mg/ml at pH 5.0 (Fig. 7 B; con- 
trol). Finally, electrophoresis of the supernatant and pellet 
fractions from solutions containing ~-Gal A (10 mg/ml) and 
BSA (2 mg/ml) incubated at varying hydrogen ion concentra- 
tions reve~ed that the increasing precipitation of c~-Gal A 
with decreasing pH was enzyme specific, as the BSA did not 
precipitate  over  this  pH  range.  Of  note,  purified  oe-N- 
acetylgalaetosamim'dase also formed aggregates when solu- 
tions containing >  500,000 U/ml were incubated at pH 6.0 
(Y. A. Ioannou, and R. J. Desnick, unpublished results). 
To determine the effects of ~x-Gal A aggregation at lower 
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Figure 6. Increasing overexpression of human ceGal A results in 
decreasing sulfation  of  the secreted enzyme. Sequentially  amplified 
AGAS.3 cells (107) were labeled with 50/~Ci of [35S]sulfate in 
sulfate-free media for 24 h.  Recombinant a-Gal A  and  CHO 
/3-hexosaminidase activities (100 U)  were immunoprecipitated 
from the cells and media and the amount of radioactive sulfate in- 
corporation was determined. Note that the incorporation of radio- 
active sulfate in secreted human c~-Gal A (e) decreased with in- 
creasing amplification  (0.08, 1.3, and 1,000 I~M Mx) and secretion, 
while the sulfate incorporation into endogenous ClIO 15-hexos- 
aminidases was essentially unchanged (￿9  No sulfate incorpora- 
tion was observed in intracellular a-Gal A (m). 
pH on its binding to the M6PR, increased concentrations of 
o~-Gal A were applied to a column of immobilized M6PR at 
pH 6.0. The binding of the purified, secreted enzyme to the 
receptor became saturated when ,~2,000 U were bound (Fig. 
8 A, inset). However, as the concentration of the applied en- 
zyme was markedly increased, the binding capacity of the 
receptor column was considerably increased (Fig. 8 A). For 
example, when 1,000,000 U/100 pl were applied, 40,000 U 
were bound. The affinity  of the bound enzyme on the M6PR 
column was determined by applying increasing concentra- 
tions of enzyme to the column, followed by sequential elu- 
tion with 0.005 mM M6P to release enzyme bound with low 
affinity and then with 5 mM M6P to release the remaining 
bound enzyme. As shown in Fig. 8 B, the relative affinity of 
,-Gal A for the M6PR column decreased when increasing 
enzyme concentrations were applied,  suggesting  that in- 
creasingly concentrated enzyme (i.e., aggregates) bound the 
receptor, albeit with decreasing affinity. 
To determine whether the increased capacity of the recep- 
tor column was compatible with the application and binding 
of enzyme aggregates in the concentrated enzyme solution, 
purified c~-Gal A (30 mg/ml) was cross-linked with EDC at 
pH 5.0 and then adjusted to pH 6.0. When 300,000 U of the 
cross-linked enzyme solution was  applied  to  the  M6PR 
column, more than 100,000 U of cross-linked enzyme were 
bound and eluted with 5 mM M6P.  In contrast, when the 
same amount and concentration of uncross-linked enzyme 
was applied, only 3,000 U were bound and eluted (Fig. 8 A). 
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purified  secreted  c~-Gal A  is 
enzyme concentration and pH 
dependent.  (A)  Precipitation 
of c~-Gal A  (10 mg/ml)  with 
decreasing  pH.  Note  that 
'~12%  of incubated  enzyme 
was precipitated at pH 6.0, the 
estimated pH of the TGN. (B) 
Turbidity  of increasing  con- 
centrations  of secreted c~-Gal 
A  at pH 5.0  (e)  and pH 7.0 
(A) in the absence of BSA. As 
a control for nonspecific pre- 
cipitation with increasing pro- 
tein  concentration,  secreted 
c~-Gal A (1 mg/ml) was mixed 
with increasing BSA concen- 
trations  (0.1-10 mg/ml) at pH 
5.0 (I). (C) SDS-PAGE of the 
supernatant  and  pellet  frac- 
tions  from mixtures  of puri- 
fied secreted c~-Gal  A (10 mg/ 
ml) and BSA (2 mg/ml) incu- 
bated at decreasing pH values. 
Note that  ot-Gal A  was pre- 
cipitated with decreasing pH, 
whereas the concentrations of 
soluble and precipitated  BSA 
were essentially unchanged. 
Discussion 
Stable Overexpression  of  Human a-Gal A 
Mx-induced  amplification of the  bicistronic  human cr 
A/DHFR expression construct in CHO cells resulted in the 
stable, high-level synthesis of active c~-Gal A, which was tar- 
geted to lysosomes as well as selectively secreted. After am- 
plification in 1 mM Mx, ~25 copies of the stably integrated 
vector transcribed sufficient ot-Gal A mRNA to produce in- 
tracellular levels of the soluble lysosomal glycosidase that 
were over 120 times the endogenous activity in  nontrans- 
fected CHO cells. The recombinant enzyme was synthesized 
in  such  large  amounts  that  ordered  crystalline  structures 
were observed in markedly dilated TGN and in numerous, 
enlarged lysosomes (Fig.  1 A  and B).  That the crystalline 
structures were composed of human a-Gal A  was demon- 
strated by immunogold labeling with affinity-purified anti- 
human u-Gal A  antibodies (Fig.  1 C and D).  Such hyper- 
trophy and dilation of the TGN has been observed in secre- 
tory cells that were stimulated to secrete (Hand and Oliver, 
1984),  or  in  response to pathologic  processes  (Hand and 
Oliver,  1983). 
Notably, ,~65 % of the synthesized enzyme was selectively 
secreted, attaining a level of u-Gal A  activity in the media 
that was 130 times greater than that of the secreted CHO en- 
zyme. Evidence for this being a  selective process, was the 
finding that the trafficking of the endogenous lysosomal en- 
zymes was not impaired, as their activity levels in the cells 
and culture medium were either unchanged or slightly de- 
creased.  These findings indicated that the M6PR-mediated 
pathway was not saturated,  and that the selective secretion 
of the recombinant enzyme was due to an alternative mech- 
anism. 
Poten  tial Mechanisms for Selective Secretion 
of a-Gal A 
Possible mechanisms for the selective secretion of the over- 
expressed lysosomal enzyme included:  (a)) a critical muta- 
tion in the oL-Gal A eDNA expression construct such as the 
elimination of an essential glycosylation site; (b) an altera- 
tion in the lysosomal protein transport and/or sorting ma- 
chinery unique to the AGA5.3 clones such that the majority 
of the highly expressed enzyme was secreted; (c) improper 
synthesis or modification of the M6P moieties on the enzyme 
due to the high level of its synthesis; and/or (d) an unusually 
low affinity of the recombinant enzyme for the M6PR. Each 
of these mechanisms was excluded experimentally. 
To rule out a possible mutation in the ot-Gal A cDNA in- 
troduced during construction and integration of the vector, 
the integrated human cr  A cDNAs from AGA5.3-1.3Mx 
and  AGA5.3-1000Mx  cells  were  PCR-amplified.  10  sub- 
clones of each were completely sequenced in both orienta- 
tions, and no mutations were identified. The possibility that 
a unique alteration in the lysosomal or secretory trafficking 
machinery occurred in the AGA5.3 ceils was eliminated by 
the amplification of another transfected clone (AGA9) which 
then selectively secreted the recombinant enzyme. That the 
M6P moiety was intact on the secreted recombinant enzyme, 
was  demonstrated  by  M6PR-binding  and  elution  studies 
(Fig. 5 A). In addition, the secreted enzyme was purified to 
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Figure 8. Purified a-Gal A aggregates can bind the M6PR. (A) 
Increasing concentrations of purified  secreted c~-Gal A  (200- 
10,000,000 U/100/~1) were applied to the M6PR column at pH 6.0 
in a constant volume of 100 #1. When dilute concentrations of 
u-Gal A were applied, the column was saturated at about 2,000 U 
(inset). Application of increasing c~-Gal A concentrations resulted 
in a marked increase in enzyme binding to the column; i.e., when 
1,000,000 and t0,000,000 U were applied, greater than 20,000 and 
50,000 U were bound, respectively. (B) The same concentrations 
of recombinant c~-Gal A were applied to the column as in (A). After 
washing of the column with binding buffer at pH 6.0, the column 
was eluted with five column volumes of washing buffer containing 
0.005 mM M6P to elute enzyme bound with low affinity and then, 
with the same buffer containing 5 mM M6P to release the remain- 
ing enzyme. The relative affinity  of  binding is expressed as one over 
the percent of enzyme eluted at 0.005 mM M6P. 
homogeneity and its physical and kinetic properties as well 
as its NH2-terminal sequence were the same as those of the 
native  lysosomal  enzyme  and  the  purified  intracellular 
recombinant enzyme (Y. A. Ioannou and R. L Desnick, un- 
published results). The only notable differences between the 
recombinant intracellular  and  secreted  enzymes were  in 
their carbohydrate structures and their sulfation. Whereas 
the  intracellular  enzyme  had  its  carbohydrate  moieties 
trimmed in the lysosome and was not sulfated, the secreted 
enzyme was glycosylated and sulfated, consistent with its 
transport through the secretory pathway.  Furthermore, to 
prove that the secretion of human ot-Gal A was not unique 
to  this  protein,  the  cDNAs  encoding  two  other  human 
lysosomal hydrolases, ct-N-acetylgalactosaminidase  and acid 
sphingomyelinase, also were inserted into the p91023(B)  ex- 
pression construct and amplified in transfected CHO cells 
(Table IV). Cells that were high expressors of each enzyme 
also  selectively  secreted  the  respective  phosphorylated 
recombinant enzyme into the medium. 
Overexpression Results in the Selective Secretion of 
Other Eukaryotic "Lysosomal" Enzymes 
In yeast, the overexpression of vacuolar carboxypeptidase Y 
resulted in the selective secretion of over 50% of the synthe- 
sized enzyme, as the normally glycosylated precursor form 
(Stevens et al., 1986). Similarly, overexpression of the yeast 
vacuolar proteinase A gene resulted in the selective secretion 
of its enzyme precursor (Rothman et al., 1986).  h has been 
proposed that these yeast glycoproteins have subcellular tar- 
geting signals located in their peptide sequences that recog- 
nize a specific sorting receptor. However, the fact that these 
overproduced proteins were secreted, whereas other vacuo- 
lar proteins were not, precluded the existence of a specific 
receptor that became saturated. It is notable that the levels 
of secretion of these yeast vacuolar proteins were propor- 
tional to their gene dosage, mRNA levels, and degree of ex- 
pression. 
In transformed murine fibroblasts (NIH 3T3  cells),  the 
major excreted protein (MEP) is cathepsin L (Sahagian et 
al., 1982; Troen et al., 1987), a lysosomal cysteine protease 
with functional M6P moieties. The synthesis and selective 
secretion of MEP are markedly increased in response to vi- 
ral transformation, certain growth factors, and tumor pro- 
rnoters (Dong et al., 1989; Dong and Sahagian, 1990).  For 
example, transformation of NIH 3T3 cells with Kirsten virus 
resulted in a 25-fold increase in the synthesis of MEP, caus- 
ing the enzyme to be selectively secreted. The mechanism 
for the selective secretion of MEP in the Kirsten virus-trans- 
formed cells apparently results from the low affinity  of MEP 
for the M6PR (Dong et al.,  1989;  Lazzarino and Gabel, 
1990). Of  note, the amplified expression of  routine or human 
cathepsin L in NIH 3T3 cells resulted in levels of secretion 
comparable to those in NIH 3T3  cells transformed by the 
Kirsten virus (Kane et al., 1988). In addition, human cathep- 
sin D has been stably transfected into BHK cells, but the in- 
tracellular and secreted levels of recombinant enzyme were 
only several times higher than in control cells (Horst and 
Hasilik, 1991); immunoprecipitation of the intracellular and 
secreted forms of cathepsin D  focused on their differential 
glycosylation; the mechanism of secretion was not inves- 
tigated. These examples illustrate mechanisms that might ac- 
count for the selective secretion of their respective proteins. 
However,  these mechanisms have been eliminated for the 
selective secretion of overexpressed human (~-Gal A, since 
the M6PR-mediated pathway was not saturated, nor was the 
affinity of the a-Gal A  M6P moieties for the receptor de- 
creased. 
Of interest, the selective secretion of the yeast vacuolar 
proteins, murine and human cathepsins L, human cathepsin 
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Figure 9.  Aggregation-secretion 
model  for selective secretion  of 
human t~-Gal A overexpressed in 
CHO  cells.  High-level  overex- 
pression in CHO cells of human 
~-Gal A or other lysosomal en- 
zymes that normally are targeted 
to the  lysosome  results  in their 
selective  secretion  due  to  their 
aggregation and the resultant in- 
accessibility  of their  MtPR sig- 
nals. The enzyme undergoes nor- 
mal posttranslational  processing 
until it arrives in the TGN, where 
the overexpressed enzyme under- 
goes protein-protein  interactions 
and  forms  smaller  soluble  and 
larger particulate aggregates (Fig. 
1, A-D), due to lower pH of the 
TGN. The TGN becomes dilated 
with  the  overexpressed  enzyme 
(see Fig.  1, B and D). Some ag- 
gregates and soluble enzyme with 
exposed M6P signals are trafficked 
to lysosomes, while the majority 
of aggregates whose M6P are not 
accessible are exocytosed by de- 
fault  via the  constitutive  secre- 
tory  pathway. In  addition,  de- 
creased  sulfation  may  occur as 
the tyrosines  in the enzyme ag- 
gregates  destined  for  secretion 
are unavailable to the sulfotrans- 
ferase.  This model  may explain 
the  selective  secretion  of other 
overexpressed proteins  that  nor- 
mally are targeted to specific or- 
ganelles. 
D  in mammary tumors (Capony et al.,  1989; Rochefort et 
al., 1989,  1990), recombinant secreted human o~-Gal A, and 
~-N-acetylgalactosaminidase all share the common feature 
of overexpression. In fact, the butyrate stimulation experi- 
ments emphasized that even a transient increase in the o~-Gal 
A  mRNA levels in transfected cells could result in the in- 
creased secretion of o~-Gal A. The increase in secretion was 
proportional to the increase in a-Gal A mRNA levels (Fig. 
3). Consistent with this finding, the transient expression of 
various lysosomal enzymes in COS-1  cells results in their 
respective secretion into the medium (Y. Ioannou and R. J. 
Desnick, unpublished results). Analogously, the overexpres- 
sion  of  two  ER  resident  proteins,  ERp72  and  protein 
disulfide isomerase was characterized by their accumulation 
in the ER and their selective secretions (Dorner et al., 1990). 
The overexpression of ERp72 did not cause secretion of en- 
dogenous protein disulfide isomerase and vice versa, indi- 
cating  a  selective-secretion  mechanism,  albeit  unknown, 
unique to the overexpressed ER proteins. 
The Aggregation-Secretion  Hypothesis: 
Overexpression Leads to Aggregation, Precipitation, 
and Rerouting Via the Constitutive 
Secretion Pathway 
An "aggregation-secretion" model is proposed to account for 
the rerouting of human ot-Gal A  as a  prototype for over- 
produced lysosomal enzymes and other targeted proteins. As 
depicted in Fig. 9, the overproducedenzyme is normally syn- 
thesized  and  processed until  it reaches  the  TGN.  In this 
structure, the overproduced enzyme is accumulated and sub- 
jected to a  markedly more acidic  environment,  pH "~6.0 
(Griffiths and Simons,  1986), which causes increased pro- 
tein-protein interactions that generate soluble and particu- 
late a-Gal A aggregates. As a result of such aggregation, the 
enzyme's M6P moieties become inaccessible or less accessi- 
ble for binding to the M6PR. The aggregates with inaccessi- 
ble M6P moieties, by default, are rerouted via the constitu- 
tive  secretory  pathway  (Helms  et  al.,  1990).  A  certain 
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form soluble and particulate aggregates  which can interact 
with the M6PR and would be transported to lysosomes, ac- 
counting  for the  high-level  intracellular  accumulation  of 
ot-Gal A. In addition, a portion of  the secreted enzyme would 
become soluble and would be internalized  and targeted to 
lysosomes after binding to the M6PR on the cell surface. An 
alternative  hypothesis for the delivery of enzyme aggregates 
to  lysosomes could  involve  autophagy  of the  aggregate- 
containing  portions of the TGN. 
Three lines of experimental evidence support the aggrega- 
tion-secretion  model.  First,  purified  secreted  ot-Gal A 
formed precipitates in vitro with increasing enzyme concen- 
tration and decreasing  pH (Fig.  7).  In fact,  ,,o12% of the 
purified enzyme was precipitated at a concentration  of 10 
mg/ml and a pH of 6.0, consistent with the estimated hydro- 
gen ion concentration  of the TGN, and the fact that crystal- 
line structures  were abundant  in dilated TGN (Fig.  1 B and 
D). It should be noted that the protein concentration  in cells 
and their organdies is very high (e.g., > 200 mg/ml in liver; 
Srere,  1987),  and  that  the  ot-Gal A  concentration  of 10 
mg/ml may be much less than that in the TGN of  the AGA5.3- 
1000Mx cell line. Second, the secreted form of  human c~-Gal 
A  was  sulfated  as expected, since secreted molecules are 
usually sulfated in the TGN as they proceed through the con- 
stitutive  secretory pathway  (Huttner and Baeuerle,  1988). 
The human ot-Gal A sequence contains two tyrosine residues 
(Y55 and Y57) within an amino acid context that conforms 
to four of the five guidelines  for tyrosine sulfation (Huttner 
and  Baeuerle,  1988).  Of note,  the percent of sulfated  se- 
creted enzyme decreased with increasing enzyme secretion, 
whereas the sulfation levels of  the endogenous CHO/3-hexos- 
aminidase  isozymes were essentially  unchanged  (Fig.  6 A 
and B). This finding suggested that the sulfotransferase in the 
TGN was unable to sulfate all of the secreted ot-Gal A, pre- 
sumably due to the formation  of enzyme aggregates which 
hindered access of the tyrosine moieties to the sulfotransfer- 
ase.  Furthermore,  it should  be noted that  analysis  of the 
oligosaccharide  structures  on the secreted enzyme revealed 
phosphorylated high mannose,  complex, and hybrid chains 
(Y. A. Ioannou, and R. J. Desnick, unpublished  results),  in- 
dicating  that  the  enzyme  was  soluble  and  appropriately 
modified in the Golgi complex. This  finding is consistent 
with the sulfation  data and supports the occurrence of en- 
zyme aggregation  in the TGN.  However, it should  also be 
noted that other possible mechanisms may be responsible for 
the selective secretion of the overexpressed enzyme, includ- 
ing some as yet unknown receptor,  binding protein, or other 
component of protein sorting.  Third,  when high concentra- 
tions of purified,  secreted ot-Gal A at pH 6.0 were applied 
to the M6PR column, the amount of enzyme bound was in- 
creased markedly (Fig. 8), consistent with the formation and 
binding of enzyme aggregates.  The affinity of enzyme bind- 
ing decreased when higher concentrations  were applied to 
the column, suggesting that the larger aggregates  were less 
tightly  bound due to their mass or steric configuration.  A 
cross-linked  enzyme  concentrate  similarly  bound  to  the 
receptor column, indicating that cross-linked aggregates had 
available M6P signals  for receptor binding.  Thus,  these in 
vitro studies indicated that high concentrations  of the recom- 
binant enzyme aggregated, and that some of these aggregates 
bound to the M6PR, albeit with decreased binding affinity. 
Analogously, enzyme aggregates with exposed M6P signals 
that formed in the AGA5.3-1000Mx cells would be targeted 
to the lysosome, while aggregates  in which critical  M6P 
moieties were masked, presumably would be secreted by de- 
fault via the secretory pathway, consistent with the "aggrega- 
tion-secretion" hypothesis. 
Thus,  the  cellular  response  to  the  overproduction  of 
lysosome-targeted proteins is to transport those containing 
available M6P residues to the lysosome and to reroute the 
majority of the overproduced (and presumably aggregated) 
proteins through the constitutive  secretion pathway. Clearly, 
the amplification  series of overexpressing  c~-Gal A  CHO 
cells provides an unique experimental  mammalian  system to 
efficiently  characterize  the  biosynthesis,  posttranslational 
modifications,  and mechanisms  responsible for the lysoso- 
mal targeting  and selective secretion of this prototype lyso- 
somal enzyme, thereby providing further insight into the na- 
ture of protein transport and sorting in mammalian  ceils. In 
addition,  the fact that large amounts of recombinant human 
ot-Gal A are secreted by CHO cells permits the scaled-up 
production and purification  of the recombinant  enzyme for 
crystallography  and for trials of  enzyme replacement therapy 
in patients with Fabry disease.  Thus,  the overexpression  of 
lysosomal and perhaps other targeted proteins in CHO cells 
provides a convenient approach to study protein biosynthesis 
and sorting as well as produce large amounts of the protein 
for structural  analyses and/or therapeutic  applications. 
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